Sherif S. Morgan, Ph.D.
Affiliations: | 2009 | Cancer Biology | University of Arizona, Tucson, AZ |
Area:
Cell Biology, Molecular Biology, OncologyGoogle:
"Sherif Morgan"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Emmanuelle J. Meuillet | grad student | 2009 | University of Arizona | |
| (The bile acid, deoxycholic acid, modulates IGF-IR function in colon cancer cells.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Morgan SS, Cranmer LD. (2014) Vorinostat synergizes with ridaforolimus and abrogates the ridaforolimus-induced activation of AKT in synovial sarcoma cells. Bmc Research Notes. 7: 812 |
| Morgan SS, Feldman R, Cranmer LD. (2014) Identification of putative molecular targets in Merkel cell carcinoma. Journal of Clinical Oncology. 32 |
| Cranmer LD, Morgan SS, Feldman R, et al. (2014) Biomarker patterns of metastatic melanoma with implications for therapy. Journal of Clinical Oncology. 32 |
| Cruz-Muñoz W, Jaramillo ML, Man S, et al. (2012) Roles for endothelin receptor B and BCL2A1 in spontaneous CNS metastasis of melanoma. Cancer Research. 72: 4909-19 |
| Morgan SS, Cranmer LD. (2012) Abstract 2820: Vorinostat abrogates ridaforolimus-induced activation of Akt in synovial sarcoma cells: A possible rationale for their synergism Cancer Research. 72: 2820-2820 |
| Meuillet EJ, Mash EA, Olsen E, et al. (2011) Abstract A242: A novel AKT inhibitor, PH427, prevents UVB-induced signaling in human squamous skin carcinomas. Molecular Cancer Therapeutics. 10 |
| Cranmer LD, Engelhardt C, Morgan SS. (2010) Treatment of unresectable and metastatic cutaneous squamous cell carcinoma. The Oncologist. 15: 1320-8 |
| Cranmer LD, Jeter JM, Morgan SS, et al. (2010) Whole-brain radiation therapy in melanoma: an open question. The Lancet. Oncology. 11: 13; author reply 13- |